If you've been diagnosed with lung cancer, your doctor or oncologist will discuss suitable treatments with you. The two main types of lung cancer — small-cell lung cancer (SCLC) and non-small ...

Retevmo (selpercatinib) is a medicine that is used in adults for certain types of non-small-cell lung cancer (NSCLC) that have a certain fusion in a gene known as receptor tyrosine kinase (RET).

This week Bobbi Conner talks with Dr. Miriam Alexander about advances in lung cancer treatment in recent years. Dr. Alexander ...

Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a ...

In a significant breakthrough, the world’s first mRNA lung cancer vaccine trials have been launched across seven countries, ...

Lung cancer, the most commonly diagnosed cancer in China, has only a 19.7% five-year survival rate in the country. The disease in non-smokers is prevalent and younger patients account for an ...

Discover how combining photodynamic therapy (PDT) with cisplatin enhances lung cancer treatment, promoting tumor cell ...

Comparison of targetable driver gene mutation frequencies in lung adenocarcinoma and lung squamous cell carcinoma. Lung cancer remains one of the leading causes of cancer-related mortality, with ...

Johnson & Johnson's MARIPOSA study shows Rybrevant plus Lazcluze significantly extends overall survival in first-line ...

Researchers hypothesized that increased counseling, NRT provision, and screening for SDOH, with referrals to community-based services, would improve tobacco abstinence among current smokers.